This morning, Star Scientific was alerted to the filing of a purported class
action lawsuit against the Company in the U.S. District Court for the
Eastern District of Virginia (Richmond Division). The complaint, which
lists one named plaintiff, focuses on the validity of the Company's research
and development related to the active ingredient in the Company's now
marketed dietary supplements and cosmetic products. Star Scientific is
proud of its worthy science-based products, as well as the fact that these
products are used by thousands of satisfied regular customers. We stand
behind our scientific research, and that of other credentialed
third-parties, that has been conducted on our anatabine compound as well as
the reporting on the results of that research. Accordingly, the Company
will vigorously contest each of the allegations in the complaint. We are
confident that the meritless nature of this lawsuit will cause it to be
ultimately dismissed.

In a cursory review of the complaint, the Company noted, with interest, that
the purported lead class action plaintiff is an individual who purchased 500
shares of Star Scientific stock on January 23, 2013, and held the stock for
only seven days, selling his 500 shares on January 30, 2013. For a range of
compelling reasons, it is difficult to conceive of a more inappropriate
class action plaintiff representative. In addition, the lawsuit seems to
result from a wide, and until now, unsuccessful search by plaintiffs' law
firms seeking to find anyone to bring any kind of action without regard to
its merits.